Michael S Anglesio Selected Research

Sertoli-Leydig Cell Tumor

8/2015	The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
1/2012	Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael S Anglesio Research Topics

Disease

27	Neoplasms (Cancer) 11/2022 - 09/2004
17	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 04/2011
15	Carcinoma (Carcinomatosis) 04/2022 - 10/2010
3	Endometrioid Carcinoma 02/2019 - 10/2010
2	Endometriosis 01/2022 - 12/2017
2	Hypoxia (Hypoxemia) 01/2017 - 04/2011
2	Ovarian Epithelial Carcinoma 01/2017 - 03/2014
2	Sertoli-Leydig Cell Tumor 08/2015 - 01/2012
1	Turcot syndrome 01/2022
1	Breast Neoplasms (Breast Cancer) 06/2020
1	Endometrial Neoplasms (Endometrial Cancer) 04/2019
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 06/2017
1	Pleuropulmonary blastoma 01/2012
1	Clear Cell Adenocarcinoma 04/2011
1	Hypercalcemia (Milk Alkali Syndrome) 04/2011
1	Wilms Tumor (Wilm's Tumor) 09/2004

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2013
6	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 10/2009
4	PlatinumIBA 11/2022 - 04/2011
4	Proteins (Proteins, Gene)FDA Link 04/2022 - 10/2010
4	Small Interfering RNA (siRNA)IBA 01/2017 - 09/2007
3	RNA (Ribonucleic Acid)IBA 11/2022 - 12/2017
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019 - 09/2004
2	taxaneIBA 04/2022 - 03/2014
2	ChromatinIBA 01/2022 - 01/2022
2	Hormones (Hormone)IBA 01/2020 - 08/2013
2	Biological ProductsIBA 10/2019 - 06/2017
2	ParaffinIBA 10/2019 - 12/2017
2	Sunitinib (Sutent)FDA Link 01/2017 - 04/2011
2	Ribonucleases (Ribonuclease)IBA 08/2015 - 01/2012
2	MicroRNAs (MicroRNA)IBA 08/2015 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 09/2012 - 04/2011
1	SilverIBA 03/2022
1	ChemokinesIBA 12/2020
1	Acid CeramidaseIBA 06/2020
1	Estrogen ReceptorsIBA 06/2020
1	mahuang-tangIBA 01/2020
1	Type 4 Fibroblast Growth Factor ReceptorIBA 09/2019
1	CateninsIBA 02/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	GTP Phosphohydrolases (GTPases)IBA 01/2019
1	Formaldehyde (Formol)FDA Link 12/2017
1	NucleotidesIBA 12/2017
1	ElementsIBA 12/2017
1	Retroelements (Retrotransposon)IBA 12/2017
1	Lys01IBA 01/2017
1	Forkhead Box Protein L2IBA 01/2017
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2015
1	Hematoxylin (Haematoxylon)IBA 11/2015
1	Indicators and Reagents (Reagents)IBA 12/2014
1	LipidsIBA 03/2014
1	AntibodiesIBA 02/2014
1	HLA-DR alpha-ChainsIBA 09/2012
1	CytokinesIBA 09/2012
1	HLA-DPA1 antigen (HLA DPA1)IBA 09/2012
1	liposomal doxorubicin (Doxil)FDA Link 08/2012
1	EndoribonucleasesIBA 01/2012
1	Ribonuclease III (RNase III)IBA 01/2012
1	Angiogenesis InhibitorsIBA 04/2011
1	InterleukinsIBA 04/2011
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2011
1	Cyclin D1IBA 09/2007
1	AnkyrinsIBA 09/2004

Therapy/Procedure

7	Therapeutics 11/2022 - 01/2013
5	Drug Therapy (Chemotherapy) 04/2022 - 04/2011
1	Neoadjuvant Therapy 04/2022
1	Precision Medicine 03/2022
1	Radiotherapy 01/2022
1	Immunotherapy 04/2019
1	Lasers (Laser) 06/2013